Shock and Early Death in Hematologic Patients with Febrile Neutropenia
Author(s) -
Mariana Guaraná,
Márcio Nucci,
Simone Aranha Nouér
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01250-19
Subject(s) - medicine , neutropenia , bacteremia , odds ratio , septic shock , confidence interval , univariate analysis , gastroenterology , epidemiology , surgery , antibiotics , sepsis , multivariate analysis , microbiology and biotechnology , chemotherapy , biology
Empirical antibiotic therapy with a beta-lactam is the standard of care in febrile neutropenia (FN) and is given to prevent early death. The addition of vancomycin is recommended in certain circumstances, but the quality of evidence is low, reflecting the lack of clinical data.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom